All Practice Exams

Free Practice Questions for Iran Anesthesiology Specialty Board Exam

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Exam Review

Key Facts: Iran Anesthesiology Specialty Board Exam Exam

150

Total four-option multiple-choice questions on the national written board examination

Sanjesh Pezeshki Specialty Board Examination Regulations

70% (105/150)

Mandatory written passing threshold required to advance to the clinical OSCE/oral examination

Council for Medical and Specialized Education, Ministry of Health

210 min

Total duration of the written examination, allocating approximately 84 seconds per clinical item

National Center for Health Assessment Exam Administration Protocol

0

Negative marking: incorrect responses carry zero penalty, making full completion essential

Secretariat for the Council for Medical and Specialized Education

1 time/yr

National board examination administration frequency, traditionally held annually in Shahrivar (September)

Sanjesh Pezeshki National Specialty Examination Calendar

The Iranian Anesthesiology Specialty Board Examination (بورد تخصصی بیهوشی) is the definitive national certification exam for anesthesiology specialists in Iran. The written phase consists of 152 multiple-choice questions over 240 minutes referencing Miller's Anesthesia with no negative marking. A strict 70% passing standard (105/150) is required to qualify for the culminating clinical OSCE and oral board examination.

Sample Iran Anesthesiology Specialty Board Exam Practice Questions

Try these sample questions to review concepts for the Iran Anesthesiology Specialty Board Exam exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 28-year-old mechanically ventilated neurotrauma patient in the intensive care unit has been receiving a propofol infusion at 85 mcg/kg/min for 58 hours. The patient abruptly develops severe metabolic acidosis with a widened anion gap, hyperkalemia, refractory bradycardia progressing to Brugada-like electrocardiographic changes, rhabdomyolysis, and acute renal failure. Which of the following pathophysiological mechanisms underlies this life-threatening syndrome?
A.Impairment of mitochondrial fatty acid oxidation and oxidative phosphorylation chain inhibition
B.Immune-mediated idiosyncratic destruction of hepatic cytochrome P450 2B6 enzymes
C.Excessive allosteric activation of post-synaptic GABA-A receptor chloride ion channels
D.Direct pharmacological uncoupling of cardiac sarcolemmal Ryanodine receptors
Explanation: Propofol infusion syndrome (PRIS) is a catastrophic complication typically triggered by prolonged (>48 hours) high-dose (>67-83 mcg/kg/min or >4-5 mg/kg/h) propofol infusions. Its primary pathophysiology involves impaired mitochondrial entry of long-chain fatty acids (inhibition of carnitine palmitoyltransferase-I) and blockade of mitochondrial respiratory electron transport chain complexes II and IV, starving high-energy tissues like cardiac and skeletal muscle of ATP. This leads to lactic acidosis, myocyte necrosis, rhabdomyolysis, hyperkalemia, acute kidney injury, hepatomegaly, and refractory cardiogenic shock.
2A 74-year-old male with severe ischemic cardiomyopathy and end-stage congestive heart failure (ejection fraction 20%) undergoes rapid-sequence induction with etomidate 0.2 mg/kg. Which enzymatic step in the adrenal steroid synthesis pathway is directly and reversibly inhibited by this induction agent?
A.21-hydroxylase conversion of progesterone to deoxycorticosterone
B.11-beta-hydroxylase conversion of 11-deoxycortisol to cortisol
C.Aromatase conversion of testosterone to estradiol in peripheral adipose tissues
D.Cholesterol desmolase conversion of cholesterol to pregnenolone
Explanation: Etomidate contains an imidazole ring that binds the ferric iron of the cytochrome P450 enzyme 11-beta-hydroxylase (CYP11B1), dose-dependently inhibiting the conversion of 11-deoxycortisol to cortisol (and 11-deoxycorticosterone to corticosterone). Even a single clinical induction dose suppresses adrenal cortisol responsiveness to adrenocorticotropic hormone (ACTH) for 24 to 48 hours, although its marked hemodynamic stability makes it favorable for induction in fragile cardiac patients.
3An anesthesiologist administers intravenous racemic ketamine 1.5 mg/kg for anesthesia induction in an acutely traumatized patient who has been stranded in shock for 14 hours with severe sympathetic exhaustion. What hemodynamic response is most likely to occur immediately following administration?
A.Marked hypertension and reflex sinus tachycardia mediated by central vagal inhibition
B.Severe peripheral systemic vasodilation with profound reduction in afterload and bronchorrhea
C.Direct myocardial depression resulting in acute systemic hypotension and reduced cardiac output
D.No measurable change in systemic arterial pressure due to balanced central autonomic tone
Explanation: Ketamine is intrinsically a direct myocardial depressant in isolated cardiac preparations. Under normal physiological circumstances, this intrinsic negative inotropic effect is heavily overwhelmed by ketamine-induced central sympathetic stimulation and inhibition of neuronal catecholamine reuptake, yielding systemic tachycardia and hypertension. However, in critically ill patients with prolonged shock, sepsis, or autonomic depletion where endogenous catecholamine stores are fully exhausted, the unmasked direct negative inotropic and myocardial depressant effect results in unexpected, profound hypotension.
4A continuous infusion of dexmedetomidine is initiated for cooperative procedural sedation during an awake craniotomy. Which primary anatomic site and receptor mechanism account for its unique ability to produce conscious, easily arousable sedation without significant respiratory depression?
A.GABA-A receptor agonist action within the ventrolateral preoptic nucleus of the hypothalamus
B.Mu-3 opioid receptor activation within the ventral tegmental area of the midbrain
C.Dopamine D2 receptor antagonism within the substantia nigra pars compacta
D.Presynaptic alpha-2A adrenoceptor agonism within the locus coeruleus of the brainstem
Explanation: Dexmedetomidine is a highly selective alpha-2 adrenoceptor agonist (alpha-2:alpha-1 selectivity ratio of approximately 1600:1) that acts primarily on presynaptic alpha-2A receptors in the locus coeruleus of the pons. Activation inhibits adenylate cyclase and diminishes noradrenergic outflow to the cerebral cortex, mimicking natural non-rapid eye movement (NREM) stage 3 sleep. Because this sleep-like state bypasses medullary respiratory control centers, patients remain cooperative, interactive upon stimulation, and maintain spontaneous alveolar ventilation.
5During a 6-hour general anesthetic with sevoflurane using a low fresh gas flow of 0.5 L/min with warm, desiccated Baralyme absorbent, concerns arise regarding the degradation product Compound A. Which of the following statements accurately characterizes Compound A formation and its documented clinical toxicity profile?
A.Compound A is a haloalkene that causes proximal renal tubular injury in rats, prompting recommendations for fresh gas flow >= 1-2 L/min
B.Compound A is an unstable epoxide formed exclusively by the breakdown of isoflurane in soda lime
C.Compound A readily forms carbon monoxide in desiccated absorbents, causing severe intraoperative carboxyhemoglobinemia
D.Compound A is completely eliminated by the addition of 10% ethylenediaminetetraacetic acid to the breathing circuit
Explanation: Sevoflurane undergoes base-catalyzed degradation in the presence of strong alkali hydroxide CO2 absorbents (specifically barium hydroxide lime [Baralyme] and potassium hydroxide [KOH] containing soda lime) to form fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether, known as Compound A. Compound A is a haloalkene that is metabolized by renal beta-lyase into nephrotoxic thiol intermediates, causing corticomedullary junction and proximal tubular necrosis in Wistar rats. To prevent excessive accumulation in human circuits, manufacturer and safety guidelines mandate maintaining fresh gas flows of at least 1 to 2 L/min during sevoflurane administration.
6Following a weekend where the fresh gas flow was inadvertently left running continuously at 10 L/min, Monday morning's first patient undergoes general anesthesia with desflurane. Within 30 minutes, pulse oximetry displays an SaO2 reading of 91% despite an FiO2 of 1.0, while blood gas co-oximetry reveals a carboxyhemoglobin level of 32%. Which physical and chemical process produced this event?
A.Volatile degradation of desflurane into toxic formaldehyde by calcium chloride dihydrate granules
B.Carbon monoxide production caused by desflurane degradation in desiccated strong-base carbon dioxide absorbents
C.Spontaneous auto-oxidation of desflurane fluorinated carbon chains triggered by ultrasonic vaporizers
D.Exothermic combustion of rubber circuit gaskets exposed to liquid anesthetic drops
Explanation: Desiccated (completely dried-out) carbon dioxide absorbents containing strong bases such as potassium hydroxide (KOH) or sodium hydroxide (NaOH) react vigorously with volatile anesthetics containing a difluoromethyl group (-CHF2) to produce toxic quantities of carbon monoxide (CO). The propensity for CO generation follows the hierarchy: Desflurane >> Enflurane > Isoflurane >> Sevoflurane (which generates minimal CO). Leaving high fresh gas flows on over a weekend dries out the absorbent canister, priming it for massive CO generation when desflurane is introduced.
7Minimum Alveolar Concentration (MAC) is the standard metric of volatile anesthetic potency. Which of the following patient physiological conditions or concurrent medications definitively DECREASES the MAC of inhalational anesthetics?
A.Acute hypernatremia
B.Chronic alcohol abuse
C.Acute systemic hypothermia
D.Young pediatric age (6 months)
Explanation: Acute hypothermia linearly reduces MAC by approximately 2% to 5% per degree Celsius reduction in core body temperature, because lower temperatures enhance volatile anesthetic gas solubility in neural tissues and depress basal cerebral metabolic activity. Other factors that decrease MAC include acute ethanol intoxication, alpha-2 agonists, opioids, pregnancy, hyponatremia, and severe hypoxemia/hypotension.
8A 35-year-old trauma victim with an undiagnosed, small traumatic pneumothorax is placed under general anesthesia with 65% nitrous oxide and 35% oxygen. Over the next 20 minutes, peak airway pressures climb rapidly and the patient develops sudden hypotension and cyanosis. What physical property of nitrous oxide accounts for this rapid expansion of closed air-filled cavities?
A.Nitrous oxide reacts with alveolar surfactant to generate high intrapleural surface tension
B.Nitrous oxide has a 10-fold higher oil-gas partition coefficient than nitrogen
C.Nitrous oxide is actively transported across pleural membranes by sodium-potassium ATPases
D.Nitrous oxide is 34 times more soluble in blood than nitrogen, entering the cavity far faster than nitrogen can exit
Explanation: Nitrous oxide has a blood-gas partition coefficient of 0.47, making it approximately 34 times more soluble in blood than nitrogen (blood-gas partition coefficient 0.014). When nitrous oxide is delivered, it diffuses out of pulmonary capillary blood into closed, non-compliant gas-filled spaces (such as a pneumothorax, bowel lumen, middle ear, or endotracheal tube cuff) much faster than nitrogen can diffuse out of the space into the blood. In a compliant space, the volume rapidly expands; in a non-compliant space (e.g., pleural cavity), the pressure escalates dramatically, creating a life-threatening tension pneumothorax.
9A 42-year-old patient who sustained third-degree burns over 35% of their total body surface area 3 weeks ago requires debridement and grafting. Administration of succinylcholine 1.5 mg/kg for rapid-sequence induction is strictly contraindicated due to the risk of lethal hyperkalemia. Which molecular mechanism explains this exaggerated potassium efflux?
A.Proliferation and spread of immature nicotinic acetylcholine receptors across the entire postjunctional sarcolemma
B.Irreversible blockade of renal cortical potassium secretory channels by circulating myoglobin
C.Acute activation of mitochondrial potassium-ATP leak channels in vascular smooth muscle
D.Direct lysis of skeletal muscle cell membranes through membrane attack complex assembly
Explanation: Following severe denervation injuries, extensive thermal burns, prolonged immobilization, or upper/lower motor neuron lesions, skeletal muscle responds to the loss of focal motor endplate stimulation by upregulating nicotinic acetylcholine receptors (nAChRs). These receptors spread beyond the neuromuscular junction across the entire muscle sarcolemma and express immature isoforms (fetal alpha-1-beta-1-delta-gamma pentamers and adult alpha-7 homopentamers). These immature receptors remain open significantly longer when depolarized by succinylcholine, permitting massive, uncontrolled systemic potassium efflux that can raise serum potassium by 5 to 10 mEq/L, triggering fatal ventricular fibrillation.
10A 30-year-old female remains completely paralyzed with no twitches on train-of-four stimulation 3 hours after a single intubating dose of succinylcholine 1 mg/kg. Plasma pseudocholinesterase testing is ordered. Which dibucaine number and enzyme activity pattern confirms homozygous atypical (variant) butyrylcholinesterase deficiency (E1aE1a)?
A.Dibucaine number 80 with normal plasma enzyme activity
B.Dibucaine number 20 with severely prolonged duration of neuromuscular blockade
C.Dibucaine number 50 to 60 with moderate block prolongation of 30 to 45 minutes
D.Dibucaine number 95 with accelerated enzymatic clearance
Explanation: Dibucaine is a local anesthetic that inhibits normal plasma cholinesterase (butyrylcholinesterase) by approximately 80% (dibucaine number 80). In patients with the homozygous atypical enzyme variant (genotype E1aE1a, occurring in ~1 in 2,500 individuals), the abnormal enzyme is resistant to dibucaine inhibition, yielding a dibucaine number of only 16 to 25 (commonly reported as 20). Homozygotes cannot metabolize succinylcholine effectively, resulting in flaccid paralysis that typically persists for 3 to 8 hours until the drug is eliminated through slow passive renal excretion.

About the Iran Anesthesiology Specialty Board Exam Exam

The Iranian Medical Specialty Board Examination in Anesthesiology (آزمون دانشنامه تخصصی بیهوشی / بورد تخصصی بیهوشی) represents the pinnacle credential for anesthesiology specialists in the Islamic Republic of Iran. Administered under the joint authority of the Council for Medical and Specialized Education (شورای آموزش پزشکی و تخصصی) and the National Center for Health Assessment (مرکز سنجش آموزش پزشکی - Sanjesh Pezeshki) of the Ministry of Health and Medical Education (MOHME), this rigorous exit examination certifies that graduate physician anesthesiologists possess the advanced cognitive knowledge, clinical judgment, and procedural expertise required for unsupervised consultant practice and academic faculty appointments. Eligibility requires successful completion of a four-year accredited residency training program in anesthesiology and critical care at an authorized medical university in Iran, along with passing all institutional promotional examinations (ارتقا) and securing departmental sign-off. The national examination syllabus is based primarily on *Miller's Anesthesia* (the authoritative international reference designated by the National Anesthesiology Board Examination Committee). The written examination tests six core domains: Anesthesia Pharmacology (~20%), Preoperative Evaluation, Airway Management & Monitoring Technologies (~20%), Subspecialty Anesthesia (~25% covering Cardiac, Thoracic, Neuroanesthesia, Obstetric, and Pediatric anesthesia), Regional Anesthesia & Acute/Chronic Pain Medicine (~15%), Critical Care Medicine, Fluid/Transfusion Therapy & Resuscitation (~12%), and Postoperative Care, Complications & Anesthesia Safety (~8%). Examinees must attain at least 105 out of 150 written points (70%) without negative marking to advance to the multi-station clinical OSCE/oral board stage. This digital question bank is an independent English-language study adaptation created by OpenExamPrep. It contains 100 comprehensive, clinically authentic practice vignettes reflecting the clinical rigor, case scenarios, and pharmacological depth emphasized on the Iranian board examination, complete with thorough pedagogical explanations and granular distractor rationales referencing *Miller's Anesthesia*. It serves as an advanced educational study tool and is neither affiliated with nor endorsed by Sanjesh Pezeshki or the Ministry of Health and Medical Education.

Exam sponsor: National Center for Health Assessment / Sanjesh Pezeshki & Council for Medical and Specialized Education. The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The Iranian Anesthesiology Specialty Board Examination (آزمون دانشنامه تخصصی بیهوشی) is administered annually in late summer (typically late Shahrivar / mid-September) by the National Center for Health Assessment (Sanjesh Pezeshki) under the supervision of the Council for Medical and Specialized Education. The examination comprises two sequential stages: (1) A national written qualifying examination consisting of exactly 152 four-option multiple-choice questions administered in a single continuous session of 240 minutes (1.6 minutes per question). There is no negative marking: incorrect answers receive zero points without penalty. Achieving a score of at least 70% of the written total (105 of 150 points) is mandatory to pass the written stage. (2) Candidates who pass the written exam immediately qualify for the second stage: the structured clinical oral examination, consisting of multiple Objective Structured Clinical Examination (OSCE) stations, Patient Management Problem (PMP) computerized simulations, and expert board faculty vivas assessing clinical perioperative crisis management, regional nerve block sonography, and airway skills.

Time Limit

240 minutes

Passing Score

70% of the written total (105 of 150 points)

Exam / Certification Fees

Nominal annual examination fee determined by the Ministry of Health and Medical Education, payable online through sanjeshp.ir during official registration

Exam sponsor website

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

20%

Anesthesia Pharmacology (فارماکولوژی بیهوشی)

Pharmacokinetics, pharmacodynamics, receptor mechanisms, and metabolism of intravenous induction agents (propofol, etomidate, ketamine, dexmedetomidine); volatile and gaseous inhalational anesthetics (isoflurane, sevoflurane, desflurane, nitrous oxide, MAC concepts, context-sensitive half-times); depolarizing (succinylcholine) and nondepolarizing neuromuscular blockers, pseudocholinesterase variants, and reversal strategies (neostigmine, sugammadex); opioid receptor pharmacology, chest wall rigidity, context-sensitive half-time; local anesthetic mechanisms, lipid rescue for LAST; and autonomic inotropes and vasopressors.

20%

Preoperative Evaluation, Airway Management & Monitoring Technologies (ارزیابی قبل از عمل، راه هوایی و مانیتورینگ)

Preoperative physiological risk assessment, ASA physical status classification, perioperative cardiac risk stratification, preoperative medication management (antiplatelet agents, direct oral anticoagulants, ACE inhibitors); American Society of Anesthesiologists difficult airway algorithm, unanticipated difficult airway management, supraglottic airway rescue, video laryngoscopy, fiberoptic intubation, surgical cricothyrotomy; standards for basic anesthetic monitoring, capnography waveforms, invasive arterial lines, central venous pressure curves, pulmonary artery catheter waveforms, pulse contour cardiac output, transesophageal echocardiography (TEE) views, and quantitative neuromuscular monitoring (train-of-four, acceleromyography).

25%

Subspecialty Anesthesia (بیهوشی در تخصص‌های وابسته)

Cardiovascular Anesthesia: Hemodynamic goals in valvular lesions (aortic stenosis/regurgitation, mitral stenosis/regurgitation), coronary artery bypass grafting, cardiopulmonary bypass physiology, systemic heparinization, protamine reactions, separation from bypass, and aortic dissection. Thoracic Anesthesia: Double-lumen endotracheal tubes, bronchial blockers, physiology of one-lung ventilation, management of severe intraoperative hypoxemia during OLV, and mediastinal mass syndrome. Neuroanesthesia: Intracranial pressure (ICP) dynamics, cerebral perfusion pressure (CPP), cerebral autoregulation, brain protection strategies, sitting craniotomy and venous air embolism, awake craniotomy, and aneurysmal subarachnoid hemorrhage. Obstetric Anesthesia: Physiological adaptations of pregnancy, labor analgesia (epidural, CSE), anesthesia for emergency cesarean delivery, management of preeclampsia/eclampsia, postpartum hemorrhage protocols, amniotic fluid embolism, and accidental dural puncture headache. Pediatric Anesthesia: Neonatal and infant physiology, developmental pharmacology, congenital heart disease lesions (tetralogy of Fallot spells, left-to-right vs. right-to-left shunts), pediatric airway anatomy, congenital diaphragmatic hernia, pyloric stenosis resuscitation, pediatric caudal blocks, and malignant hyperthermia protocols.

15%

Regional Anesthesia & Acute/Chronic Pain Medicine (بیهوشی ناحیه‌ای و طب درد)

Applied spinal and epidural neuraxial anatomy, level of sensory block, hemodynamic sequelae of sympathectomy, post-dural puncture headache pathophysiology and epidural blood patch; ultrasound-guided upper extremity nerve blocks (interscalene, supraclavicular, infraclavicular, axillary); lower extremity blocks (femoral, adductor canal, sciatic, popliteal); fascial plane blocks (transversus abdominis plane [TAP], rectus sheath, pectoralis [PECS], serratus anterior, erector spinae plane [ESP]); local anesthetic systemic toxicity (LAST) recognition and 20% lipid emulsion therapy; multimodal acute pain management (ketamine, lidocaine infusions, gabapentinoids); and interventional chronic pain therapies (celiac plexus block, stellate ganglion block, epidural steroid injections, complex regional pain syndrome).

12%

Critical Care Medicine, Fluid/Transfusion Therapy & Resuscitation (مراقبت‌های ویژه، مایع‌درمانی و احیا)

Advanced adult cardiac life support (ACLS) and perioperative arrest rhythms; septic shock definitions, surviving sepsis campaign guidelines, vasopressor selection; mechanical ventilation in acute respiratory distress syndrome (ARDS), low tidal volume strategy, driving pressure, prone positioning; crystalloid vs. colloid resuscitation, balanced crystalloids vs. normal saline, hyperchloremic metabolic acidosis; massive transfusion protocols, tranexamic acid, viscoelastic testing (thromboelastography [TEG] and rotational thromboelastometry [ROTEM]); diagnostic evaluation and correction of complex acid-base disorders; and acute kidney injury staging and renal replacement therapy indications in the ICU.

8%

Postoperative Care, Complications & Anesthesia Safety (مراقبت‌های پس از بیهوشی، عوارض و ایمنی)

Postanesthesia care unit (PACU) phase I and II monitoring, modified Aldrete scoring, delayed emergence differential diagnosis and evaluation; postoperative nausea and vomiting (PONV) risk stratification (Apfel score) and multi-agent prophylaxis; hypothermia mechanisms, perioperative shivering management; postoperative respiratory complications (hypoxemia, atelectasis, negative-pressure pulmonary edema); perioperative visual loss; operating room electrical safety, line isolation monitors, surgical fires in oxygen-enriched environments; anesthesia machine check protocols; and crisis resource management and non-technical skills for patient safety.

Preparing for the Iran Anesthesiology Specialty Board Exam Exam

What You Need to Know

  • Passing score: 70% of the written total (105 of 150 points)
  • Assessment: The Iranian Anesthesiology Specialty Board Examination (آزمون دانشنامه تخصصی بیهوشی) is administered annually in late summer (typically late Shahrivar / mid-September) by the National Center for Health Assessment (Sanjesh Pezeshki) under the supervision of the Council for Medical and Specialized Education. The examination comprises two sequential stages: (1) A national written qualifying examination consisting of exactly 152 four-option multiple-choice questions administered in a single continuous session of 240 minutes (1.6 minutes per question). There is no negative marking: incorrect answers receive zero points without penalty. Achieving a score of at least 70% of the written total (105 of 150 points) is mandatory to pass the written stage. (2) Candidates who pass the written exam immediately qualify for the second stage: the structured clinical oral examination, consisting of multiple Objective Structured Clinical Examination (OSCE) stations, Patient Management Problem (PMP) computerized simulations, and expert board faculty vivas assessing clinical perioperative crisis management, regional nerve block sonography, and airway skills.
  • Time limit: 240 minutes
  • Exam / certification fees: Nominal annual examination fee determined by the Ministry of Health and Medical Education, payable online through sanjeshp.ir during official registration Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Iran Anesthesiology Specialty Board Exam: Suggested Study Strategy

1Master Miller's Anesthesia core chapters thoroughly: Emphasize intravenous and inhalational pharmacokinetics, neuromuscular blockade monitoring, and autonomic receptor pharmacology, as basic and applied pharmacology represents 20% of the written examination.
2Internalize hemodynamic goals for subspecialty anesthesia: Focus on distinct preload, afterload, contractility, and heart rate targets for specific valvular lesions (such as severe aortic stenosis vs. mitral regurgitation) and congenital cardiac shunts.
3Hone difficult airway algorithms and crisis protocols: Be prepared to describe the immediate step-by-step management of 'cannot intubate, cannot oxygenate' (CICO) crises, including emergency surgical cricothyrotomy indications and equipment.
4Understand regional ultrasound landmarks and local anesthetic toxicity: Practice identifying anatomical fascial planes, sonographic nerves, and immediate dosing protocols for 20% intravenous lipid emulsion in local anesthetic systemic toxicity (LAST).
5Pace yourself at 95 seconds per question: With 152 questions to be solved in 240 minutes, maintaining a disciplined pace ensures sufficient time to evaluate complex clinical vignettes and review difficult items without leaving any question unattempted.

Frequently Asked Questions

What is the Iranian Anesthesiology Specialty Board Examination (آزمون دانشنامه تخصصی بیهوشی)?

The Iranian Anesthesiology Specialty Board Examination (آزمون دانشنامه تخصصی بیهوشی), commonly referred to as the 'National Anesthesia Board' (بورد بیهوشی), is the definitive exit and certification examination administered annually by the National Center for Health Assessment (Sanjesh Pezeshki) and the Council for Medical and Specialized Education under Iran's Ministry of Health and Medical Education. Successful candidates earn the National Specialty Board Certificate (Daneshnameh Takhasosi), granting them consultant specialist privileges, eligibility for academic faculty positions, and permission to practice in major teaching hospitals and university medical centers across the country.

What is the format and duration of the written board examination?

The written examination consists of exactly 152 four-option multiple-choice questions (MCQs) administered in a single continuous session of 240 minutes (allowing an average of 1 minute and 35 seconds per item). The exam contains clinical vignettes, applied basic science scenarios, pharmacokinetics calculations, waveform interpretations, and perioperative crisis management questions. There is no negative marking: incorrect answers receive zero points without penalty.

What is the passing score required on the written examination?

Candidates must achieve a minimum score of 70% (105 points out of a written total of 150) on the written examination to pass and qualify for the clinical/oral board stage. Candidates who score below 105 fail the board examination for that academic cycle, although depending on their promotional standing, they may be awarded the specialty certificate of completion (گواهینامه تخصصی) without the Daneshnameh board credential.

What happens after passing the written board examination?

Candidates who pass the written stage advance immediately to the multi-station clinical oral examination held over the subsequent days. The oral examination incorporates Objective Structured Clinical Examination (OSCE) stations, computerized Patient Management Problems (PMP), ultrasound anatomy interpretation (e.g., nerve blocks and focused cardiac ultrasound), simulator crisis scenarios, and structured oral interviews with senior board examination committee faculty.

What are the primary reference textbooks designated for the Iranian Anesthesia Board?

The designated primary reference textbook mandated by the National Anesthesiology Board Examination Committee is Miller's Anesthesia (latest edition), supplemented by national clinical guidelines, critical care consensus statements, and cardiopulmonary resuscitation standards (AHA/ERC guidelines). Questions rigorously evaluate pharmacologic principles, physiological mechanisms, subspecialty clinical management, and safety protocols outlined in Miller.

Is this OpenExamPrep question bank an official Sanjesh Pezeshki product?

No. This question bank is an independent English-language clinical MCQ study adaptation authored by OpenExamPrep for residency review and examination preparation. The official Iranian National Specialty Board examination is conducted in Persian under the authority of Sanjesh Pezeshki and the Ministry of Health and Medical Education. This resource is not affiliated with, sponsored by, or endorsed by Sanjesh Pezeshki or the Iranian Council for Medical and Specialized Education.